Filing Details
- Accession Number:
- 0001179110-18-010698
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-20 13:46:15
- Reporting Period:
- 2018-08-16
- Accepted Time:
- 2018-08-20 13:46:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298819 | A Robert Sinnott | 3838 West Parkway Blvd Salt Lake City UT 84120 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-16 | 7,211 | $65.48 | 7,211 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-16 | 7,211 | $129.39 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-08-17 | 7,530 | $65.48 | 7,530 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-17 | 7,530 | $128.73 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock-Settles Stock appreciation Right | Disposition | 2018-08-16 | 14,645 | $0.00 | 14,645 | $65.48 |
Common Stock | Stock-Settles Stock appreciation Right | Disposition | 2018-08-17 | 15,355 | $0.00 | 15,355 | $65.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
105,355 | 2017-08-16 | 2022-03-16 | No | 4 | M | Direct |
90,000 | 2017-08-16 | 2022-03-16 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II
- Weighted average price. Price range in multiple transactions was $129.00 to $129.90, inclusive.
- Weighted average price. Price range in multiple transactions was $128.50 to $129.45, inclusive.